ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2309

Lifestyle behaviours and disease activity in patients with psoriatic arthritis: the Dutch south west psoriatic arthritis study

Batoul Hojeij1, Ilja Tchetverikov2, Marijn Vis1, Marc R Kok3, Yvonne Goekoop-Ruiterman4, Jessica Bijsterbosch5, Paul Baudoin6, Reinhard Bos7, Jos H van der Kaap8, Petra Kok9, Lindy-Anne Korswagen10 and Jolanda J Luime1, 1Erasmus MC, Rotterdam, Netherlands, 2Albert Schweitzer Hospital, Dordrecht, Netherlands, 3Maasstad Hospital, Rotterdam, Netherlands, 4Haga Hospital, the Hague, Netherlands, 5Amphia Hospital, Breda, Netherlands, 6Reumazorg Zuid West Nederland, Roosendaal, Netherlands, 7Medisch Centrum Leeuwarden, Leeuwarden, Netherlands, 8Admiraal De Ruyter Hospital, Goes, Netherlands, 9Reinier de Graaf Hospital, Delft, Netherlands, 10Franciscus Gasthuis and Vlietland, Rotterdam, Netherlands

Meeting: ACR Convergence 2025

Keywords: Cohort Study, Disease Activity, obesity, Psoriatic arthritis, Smoking

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (2305–2337) Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Comprehensive assessment of multiple lifestyle behaviours and disease activity outcomes in psoriatic arthritis (PsA) is scarce. We aim to investigate lifestyle behaviours in patients with PsA and their association with disease activity measurements.

Methods: This multicenter cohort included 938 patients newly diagnosed with PsA from the DEPAR study, between 2013 and 2023. Lifestyle behaviours were assessed at baseline and included: body mass index (BMI), waist circumference, smoking, alcohol consumption and physical activity. A comprehensive lifestyle risk score was calculated (range 0 to 5) using these five lifestyle behaviours (BMI outside normal range, abdominal obesity, current smoking, no alcohol consumption, physical inactivity), with higher scores indicating more risk behaviours. No specific treatment protocols were applied. Disease activity was assessed every three months over the course of one year and included: Psoriatic Arthritis Disease Activity Score (PASDAS), disease activity in psoriatic arthritis (DAPSA), PASDAS and DAPSA low disease activity (LDA) and remission, and minimal disease activity (MDA). The associations between the lifestyle risk score and disease activity were analyzed using mixed models adjusted for baseline disease activity, study visit, age, sex, geographic origin, education and medication. Multiple imputations to handle missing data for all covariates were performed in R (version 4.4.2) using mice predictive mean matching and classification and regression trees (pmm and CART; M=20).

Results: The rate of overweight/obesity was 72%, abdominal obesity was 39% in men and 64% in women, current smoking was 22% (of them 41% classified as moderate-to-heavy smoking ( >10 cigarettes per day)), and alcohol consumption was 82% (of them 22% classified as heavy consumption) with 3% of patients physically inactive. Using multivariable analyses, a higher lifestyle risk score was associated with higher PASDAS (βadj 0.15; 95%CI 0.08, 0.23), and lower odds for achieving PASDAS-LDA (ORadj 0.59; 95%CI 0.45, 0.77), and MDA (OR adj 0.72; 95%CI 0.57, 0.90) at one year of follow-up. Similar associations were observed for DAPSA and DAPSA-LDA. Analysis of individual lifestyle behaviours showed that obesity, abdominal obesity and moderate-to-heavy current smoking, were also significantly associated with higher PASDAS and DAPSA, and lower odds for achieving PASDAS-LDA and MDA.

Conclusion: Lifestyle behaviours seem to influence one year disease activity in PsA. Adiposity and smoking were associated with higher disease activity. Patients newly diagnosed with PsA also showed unhealthy lifestyle behaviours.

Supporting image 1


Disclosures: B. Hojeij: None; I. Tchetverikov: None; M. Vis: None; M. Kok: None; Y. Goekoop-Ruiterman: None; J. Bijsterbosch: None; P. Baudoin: None; R. Bos: None; J. van der Kaap: None; P. Kok: None; L. Korswagen: None; J. Luime: None.

To cite this abstract in AMA style:

Hojeij B, Tchetverikov I, Vis M, Kok M, Goekoop-Ruiterman Y, Bijsterbosch J, Baudoin P, Bos R, van der Kaap J, Kok P, Korswagen L, Luime J. Lifestyle behaviours and disease activity in patients with psoriatic arthritis: the Dutch south west psoriatic arthritis study [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/lifestyle-behaviours-and-disease-activity-in-patients-with-psoriatic-arthritis-the-dutch-south-west-psoriatic-arthritis-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/lifestyle-behaviours-and-disease-activity-in-patients-with-psoriatic-arthritis-the-dutch-south-west-psoriatic-arthritis-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology